{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:23:47Z","timestamp":1771647827219,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,7]]},"DOI":"10.7759\/cureus.57789","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:28:25Z","timestamp":1712550505000},"source":"Crossref","is-referenced-by-count":2,"title":["Apocrine Breast Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Soumiya","family":"Samba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Bensghier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soufiane","family":"Berhili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Moukhlissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loubna","family":"Mezouar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2012-201078","article-title":"Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012","volume":"66","author":"Tan PH","year":"2013","unstructured":"Tan PH, Ellis IO. Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012. J Clin Pathol. 2013, 66:465-70. 10.1136\/jclinpath-2012-201078","journal-title":"J Clin Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10518-9","article-title":"Apocrine breast cancer: unique features of a predominantly triple-negative breast cancer","volume":"28","author":"Saridakis A","year":"2021","unstructured":"Saridakis A, Berger ER, Harigopal M, et al.. Apocrine breast cancer: unique features of a predominantly triple-negative breast cancer. Ann Surg Oncol. 2021, 28:5610-6. 10.1245\/s10434-021-10518-9","journal-title":"Ann Surg Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02888.x","article-title":"An update on apocrine lesions of the breast","volume":"52","author":"O'Malley FP","year":"2008","unstructured":"O'Malley FP, Bane A. An update on apocrine lesions of the breast. Histopathology. 2008, 52:3-10. 10.1111\/j.1365-2559.2007.02888.x","journal-title":"Histopathology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(88)90257-x","article-title":"Breast gross cystic disease protein 15 in human breast cancer in culture","volume":"24","author":"Miller WR","year":"1988","unstructured":"Miller WR, Shivas AA, Franchimont P, Haagensen DE. Breast gross cystic disease protein 15 in human breast cancer in culture. Eur J Cancer Clin Oncol. 1988, 24:223-8. 10.1016\/0277-5379(88)90257-x","journal-title":"Eur J Cancer Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3599","article-title":"Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide","volume":"16","author":"Cochrane DR","year":"2014","unstructured":"Cochrane DR, Bernales S, Jacobsen BM, et al.. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res. 2014, 16:R7. 10.1186\/bcr3599","journal-title":"Breast Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2012.11.004","article-title":"Immunohistochemically defined subtypes and outcome of apocrine breast cancer","volume":"13","author":"Dellapasqua S","year":"2013","unstructured":"Dellapasqua S, Maisonneuve P, Viale G, et al.. Immunohistochemically defined subtypes and outcome of apocrine breast cancer. Clin Breast Cancer. 2013, 13:95-102. 10.1016\/j.clbc.2012.11.004","journal-title":"Clin Breast Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.05.017","article-title":"Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast","volume":"46","author":"Vranic S","year":"2015","unstructured":"Vranic S, Marchi\u00f2 C, Castellano I, et al.. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. Hum Pathol. 2015, 46:1350-9. 10.1016\/j.humpath.2015.05.017","journal-title":"Hum Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3421","article-title":"Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15","volume":"15","author":"Lehmann-Che J","year":"2013","unstructured":"Lehmann-Che J, Hamy AS, Porcher R, et al.. Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. Breast Cancer Res. 2013, 15:R37. 10.1186\/bcr3421","journal-title":"Breast Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.46.2.189-b","article-title":"Method for grading breast cancer","volume":"46","author":"Elston EW","year":"1993","unstructured":"Elston EW, Ellis IO. Method for grading breast cancer. J Clin Pathol. 1993, 46:189-90. 10.1136\/jcp.46.2.189-b","journal-title":"J Clin Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang SL","year":"2019","unstructured":"Wang SL, Fang H, Song YW, et al.. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019, 20:352-60. 10.1016\/S1470-2045(18)30813-1","journal-title":"Lancet Oncol"},{"key":"ref11","article-title":"Study on apocrine carcinoma of breast: histomorphologic features and immunohistochemical behavior","volume":"2","author":"Gayatri BG","year":"2012","unstructured":"Gayatri BG, Mondita B, Asha B, Vishal A. Study on apocrine carcinoma of breast: histomorphologic features and immunohistochemical behavior. Int J Basic Appl Med Sci. 2012, 2:190-3.","journal-title":"Int J Basic Appl Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14735\/amko2019380","article-title":"Tumor-infiltrating lymphocytes\/plasmocytes in chemotherapeutically non-influenced triple-negative breast cancers - correlation with morphological and clinico-pathological parameters","volume":"32","author":"Kole\u010dkov\u00e1 M","year":"2019","unstructured":"Kole\u010dkov\u00e1 M, Kol\u00e1\u0159 Z, Ehrmann J, Ko\u0159\u00ednkov\u00e1 G, Zl\u00e1malov\u00e1 N, Melichar B, Trojanec R. Tumor-infiltrating lymphocytes\/plasmocytes in chemotherapeutically non-influenced triple-negative breast cancers - correlation with morphological and clinico-pathological parameters. Klin Onkol. 2019, 32:380-7. 10.14735\/amko2019380","journal-title":"Klin Onkol"},{"key":"ref13","article-title":"Apocrine carcinoma of the breast presenting as a solitary cyst: cytological and histopathological study of a case","volume":"47","author":"Mardi K","year":"2004","unstructured":"Mardi K, Sharma J, Sharma N. Apocrine carcinoma of the breast presenting as a solitary cyst: cytological and histopathological study of a case. Indian J Pathol Microbiol. 2004, 47:268-70.","journal-title":"Indian J Pathol Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000671","article-title":"Pure apocrine carcinomas represent a clinicopathologically distinct androgen receptor-positive subset of triple-negative breast cancers","volume":"40","author":"Mills AM","year":"2016","unstructured":"Mills AM, E Gottlieb C, M Wendroth S, M Brenin C, Atkins KA. Pure apocrine carcinomas represent a clinicopathologically distinct androgen receptor-positive subset of triple-negative breast cancers. Am J Surg Pathol. 2016, 40:1109-16. 10.1097\/PAS.0000000000000671","journal-title":"Am J Surg Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2018.02.012","article-title":"Triple negative apocrine carcinomas as a distinct subtype of triple negative breast cancer: a case-control study","volume":"18","author":"Meattini I","year":"2018","unstructured":"Meattini I, Pezzulla D, Saieva C, et al.. Triple negative apocrine carcinomas as a distinct subtype of triple negative breast cancer: a case-control study. Clin Breast Cancer. 2018, 18:e773-80. 10.1016\/j.clbc.2018.02.012","journal-title":"Clin Breast Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15597","article-title":"Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database","volume":"8","author":"Zhang N","year":"2017","unstructured":"Zhang N, Zhang H, Chen T, Yang Q. Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database. Oncotarget. 2017, 8:24579-92. 10.18632\/oncotarget.15597","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/240210-apocrine-breast-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:28:29Z","timestamp":1712550509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/240210-apocrine-breast-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,7]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.57789","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,7]]}}}